The firm provides client experience to prominent senior executives, founders, early-employees, and high-profile companies. The firm has made a total of two investments in companies that enable artificial intelligence, deep learning, and processor architecture, as well as develop treatments for Alzheimer's and other disorders. The firm has invested in Tenstorrent and Cortexyme.
Documentaries, videos and podcasts
- Artificial intelligence (AI)Artificial intelligence (AI) is intelligence exhibited by machines.
- CortexymeCortexyme is a biotechnology company with a focus on developing therapeutics for Alzheimer's disease and other neurodegenerative diseases. It was founded in 2012 and is located in San Francisco, California.